Publications by Researcher: Sanij, E

Year	Title	Author(s)
2020	CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancer Nature Communications	Sanij, E Hannan, KM Xuan, JC Yan, SF Ahern, JE Trigos, AS Brajanovski, N Son, J Chan, KT Kondrashova, O Lieschke, E Wakefield, MJ Frank, D Ellis, S Cullinane, C Kang, J Poortinga, G Nag, P Deans, AJ Khanna, KK Mileshkin, L McArthur, GA Soong, J Berns, EMJJ Hannan, RD Scott, CL Sheppard, KE Pearson, RB
2021	Harnessing the Nucleolar DNA Damage Response in Cancer Therapy Genes	Xuan, JC Gitareja, K Brajanovski, N Sanij, E
2021	Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy Signal Transduction And Targeted Therapy	Kang, J Brajanovski, N Chan, KT Xuan, JC Pearson, RB Sanij, E
2021	CX-5461 Sensitizes DNA Damage Repair-proficient Castrate-resistant Prostate Cancer to PARP Inhibition Molecular Cancer Therapeutics	Lawrence, MG Porter, LH Choo, N Pook, D Grummet, JP Pezaro, CJ Sandhu, S Ramm, S Luu, J Bakshi, A Goode, DL Sanij, E Pearson, RB Hannan, RD Simpson, KJ Taylor, RA Risbridger, GP Furic, L
2021	The RNA helicase Ddx21 controls Vegfc-driven developmental lymphangiogenesis by balancing endothelial cell ribosome biogenesis and p53 function Nature Cell Biology	Koltowska, K Okuda, KS Gloger, M Rondon-Galeano, M Mason, E Xuan, JC Dudczig, S Chen, HJ Arnold, H Skoczylas, R Bower, NI Paterson, S Lagendijk, AK Baillie, GJ Leshchiner, I Simons, C Smith, KA Goessling, W Heath, JK Pearson, RB Sanij, E Schulte-Merker, S Hogan, BM